首页> 外文期刊>American Journal of Physiology >Downregulation of the vasopressin type 2 receptor after vasopressin-induced internalization: involvement of a lysosomal degradation pathway.
【24h】

Downregulation of the vasopressin type 2 receptor after vasopressin-induced internalization: involvement of a lysosomal degradation pathway.

机译:加压素诱导的内在化后2型加压素受体的下调:溶酶体降解途径的参与。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Vasopressin (VP) increases urinary concentration by signaling through the vasopressin receptor (V2R) in collecting duct principal cells. After downregulation, V2R reappears at the cell surface via an unusually slow (several hours) "recycling" pathway. To examine this pathway, we expressed V2R-green fluorescent protein (GFP) in LLC-PK1a cells. V2R-GFP showed characteristics similar to those of wild-type V2R, including high affinity for VP and adenylyl cyclase stimulation. V2R-GFP was located mainly in the plasma membrane in unstimulated cells, but it colocalized with the lysosomal marker Lysotracker after VP-induced internalization. Western blot analysis of V2R-GFP showed a broad 57- to 68-kDa band and a doublet at 46 and 52 kDa before VP treatment. After 4-h VP exposure, the 57- to 68-kDa band lost 50% of its intensity, whereas the lower 46-kDa band increased by 200%. The lysosomal inhibitor chloroquine abolished this VP effect, whereas lactacystin, a proteasome inhibitor, had no effect. Incubating cells at 20 degrees C to block trafficking from the trans-Golgi network reduced V2R membrane fluorescence, and a perinuclear patch developed. Cycloheximide reduced the intensity of this patch, showing that newly synthesized V2R-GFP contributed significantly to its appearance. Cycloheximide also inhibited the reappearance of cell surface V2R after downregulation. We conclude that after downregulation, V2R-GFP is delivered to lysosomes and degraded. Reappearance of V2R at the cell surface depends on new protein synthesis, partially explaining the long time lag needed to fully reestablish V2R at the cell surface after downregulation. This degradative pathway may be an adaptive response to allow receptor-ligand association in the hypertonic and acidic environment of the renal medulla.
机译:血管加压素(VP)通过收集血管主细胞中的血管加压素受体(V2R)发出信号来增加尿液浓度。下调后,V2R通过异常缓慢(几个小时)的“循环”途径重新出现在细胞表面。为了检查该途径,我们在LLC-PK1a细胞中表达了V2R绿色荧光蛋白(GFP)。 V2R-GFP显示出与野生型V2R相似的特征,包括对VP和腺苷酸环化酶的高亲和力。 V2R-GFP主要位于未刺激细胞的质膜中,但在VP诱导的内化作用后,它与溶酶体标记Lysotracker共定位。 V2R-GFP的蛋白质印迹分析显示,VP处理前,有一个57-68kDa的宽条带,在46和52kDa处有一个双峰。 VP暴露4小时后,从57-68kDa的条带失去了50%的强度,而较低的46-kDa的条带增加了200%。溶酶体抑制剂氯喹取消了这种VP作用,而蛋白酶体抑制剂乳胞素没有作用。在20摄氏度下孵育细胞以阻止来自反高尔基网络的运输,减少了V2R膜荧光,并形成了核周膜。环己酰亚胺降低了该贴剂的强度,表明新合成的V2R-GFP对其外观起了重要作用。环己酰亚胺在下调后也抑制细胞表面V2R的重新出现。我们得出结论,在下调后,V2R-GFP被递送至溶酶体并降解。 V2R在细胞表面的重新出现取决于新的蛋白质合成,部分解释了下调后在细胞表面完全重建V2R所需的长时间滞后。该降解途径可以是适应性反应,以在肾髓质的高渗和酸性环境中允许受体-配体缔合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号